{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:53:52Z","timestamp":1772708032903,"version":"3.50.1"},"publisher-location":"Cham","reference-count":191,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030829834","type":"print"},{"value":"9783030829841","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/164_2021_516","type":"book-chapter","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T23:32:35Z","timestamp":1635291155000},"page":"119-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Substrates and Inhibitors of Organic Cation Transporters (OCTs) and Plasma Membrane Monoamine Transporter (PMAT) and Therapeutic Implications"],"prefix":"10.1007","author":[{"given":"Heinz","family":"B\u00f6nisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"516_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijpharm.2010.12.037","volume":"406","author":"R Agu","year":"2011","unstructured":"Agu R, MacDonald C, Cowley E, Shao D, Renton K, Clarke DB, Massoud E (2011) Differential expression of organic cation transporters in normal and polyps human nasal epithelium: implications for in vitro drug delivery studies. Int J Pharm 406:49\u201354","journal-title":"Int J Pharm"},{"key":"516_CR2","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1021\/jm8003152","volume":"51","author":"G Ahlin","year":"2008","unstructured":"Ahlin G, Karlsson J, Pedersen JM, Gustavsson L, Larsson R, Matsson P, Norinder U, Bergstr\u00f6m CAS, Artursson P (2008) Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. J Med Chem 51:5932\u20135942","journal-title":"J Med Chem"},{"key":"516_CR3","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.neuropharm.2006.01.005","volume":"50","author":"A Amphoux","year":"2006","unstructured":"Amphoux A, Vialou V, Drescher E, Br\u00fcss M, Mannoury La Cour C, Rochat C, Millan MJ, Giros B, B\u00f6nisch H, Gautron S (2006) Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology 50:941\u2013952","journal-title":"Neuropharmacology"},{"key":"516_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2010.02.012","volume":"634","author":"A Amphoux","year":"2010","unstructured":"Amphoux A, Millan MJ, Cordi A, B\u00f6nisch H, Vialou V, Mannoury la Cour C, Dupuis DS, Giros B, Gautron S (2010) Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: a comparison to human alpha 1- and alpha 2-adrenoceptor subtypes. Eur J Pharmacol 634:1\u20139","journal-title":"Eur J Pharmacol"},{"key":"516_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/tpj.2015.78","volume":"15","author":"C Arimany-Nardi","year":"2015","unstructured":"Arimany-Nardi C, Koepsell H, Pastor-Anglada M (2015) Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions. Pharmacogenomics J 15:473\u2013487","journal-title":"Pharmacogenomics J"},{"key":"516_CR6","doi-asserted-by":"publisher","first-page":"e0194171","DOI":"10.1371\/journal.pone.0194171","volume":"13","author":"E Barengolts","year":"2018","unstructured":"Barengolts E, Green SJ, Eisenberg Y, Akbar A, Reddivari B, Layden BT, Dugas L, Chlipala G (2018) Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease. PLoS One 13:e0194171","journal-title":"PLoS One"},{"key":"516_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.nucmedbio.2008.12.010","volume":"36","author":"M Bayer","year":"2009","unstructured":"Bayer M, Ku\u00e7i Z, Sch\u00f6mig E, Gr\u00fcndemann D, Dittmann H, Handgretinger R, Bruchelt G (2009) Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells. Nucl Med Biol 36:287\u2013294","journal-title":"Nucl Med Biol"},{"key":"516_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10048-010-0254-5","volume":"12","author":"ML Becker","year":"2011","unstructured":"Becker ML, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, Stricker BH (2011) OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users. Neurogenetics 12:79\u201382","journal-title":"Neurogenetics"},{"key":"516_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1124\/mol.63.3.489","volume":"63","author":"D Bednarczyk","year":"2003","unstructured":"Bednarczyk D, Ekins S, Wikel JH, Wright SH (2003) Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1. Mol Pharmacol 63:489\u2013498","journal-title":"Mol Pharmacol"},{"key":"516_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1124\/jpet.113.203257","volume":"346","author":"M Belzer","year":"2013","unstructured":"Belzer M, Morales M, Jagadish B, Mash EA, Wright SH (2013) Substratedependent ligand inhibition of the human organic cation transporter OCT2. J Pharmacol Exp Ther 346:300\u2013310","journal-title":"J Pharmacol Exp Ther"},{"key":"516_CR11","doi-asserted-by":"publisher","first-page":"C1521","DOI":"10.1152\/ajpcell.00622.2005","volume":"290","author":"J Biermann","year":"2006","unstructured":"Biermann J, Lang D, Gorboulev V, Koepsell H, Sindic A, Schr\u00f6ter R, Zvirbliene A, Pavenst\u00e4dt H, Schlatter E, Ciarimboli G (2006) Characterization of regulatory mechanisms and states of human organic cation transporter 2. Am J Physiol Cell Physiol 290:C1521\u2013C1531","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"516_CR501","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF00508057","volume":"303","author":"H B\u00f6nisch","year":"1978","unstructured":"B\u00f6nisch H (1978) Further studies on the extraneuronal uptake and metabolism of isoprenaline in the perfused rat heart. Naunyn Schmiedeberg\u2019s Arch Pharmacol 303(2):121\u2013131. https:\/\/doi.org\/10.1007\/BF00508057. PMID: 673019","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"516_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000137422","volume":"21","author":"H B\u00f6nisch","year":"1980","unstructured":"B\u00f6nisch H (1980) Extraneuronal transport of catecholamines. Pharmacology 21:93\u2013108. https:\/\/doi.org\/10.1159\/000137422","journal-title":"Pharmacology"},{"issue":"3","key":"516_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/BF00497669","volume":"323","author":"H B\u00f6nisch","year":"1983","unstructured":"B\u00f6nisch H, Rodrigues-Pereira E (1983) Uptake of 14C-tyramine and release of extravesicular 3H-noradrenaline in isolated perfused rabbit hearts. Naunyn Schmiedebergs Arch Pharmacol 323(3):233\u2013244. https:\/\/doi.org\/10.1007\/BF00497669","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"516_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/BF00692909","volume":"328","author":"H B\u00f6nisch","year":"1985","unstructured":"B\u00f6nisch H, Bryan LJ, Henseling M, O\u2019Donnell SR, Stockmann P, Trendelenburg U (1985) The effect of various ions on uptake2 of catecholamines. Naunyn Schmiedebergs Arch Pharmacol 328:407\u2013416. https:\/\/doi.org\/10.1007\/BF00692909","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"516_CR15","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1124\/jpet.105.091223","volume":"315","author":"DL Bourdet","year":"2005","unstructured":"Bourdet DL, Pritchard JB, Thakker DR (2005) Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3). J Pharmacol Exp Ther 315:1288\u20131297","journal-title":"J Pharmacol Exp Ther"},{"key":"516_CR16","doi-asserted-by":"publisher","first-page":"7581","DOI":"10.3390\/ijms21207581","volume":"21","author":"MA Bowman","year":"2020","unstructured":"Bowman MA, Vitela M, Clarke KM, Koek W, Daws LC (2020) Serotonin transporter and plasma membrane monoamine transporter are necessary for the antidepressant-like effects of ketamine in mice. Int J Mol Sci 21:7581. https:\/\/doi.org\/10.3390\/ijms21207581","journal-title":"Int J Mol Sci"},{"key":"516_CR17","doi-asserted-by":"crossref","unstructured":"Burckhardt Y, Koepsell H (2013) Organic anion and cation transporters in renal elimination of drugs. In: Seldin and Giebisch\u2019s the kidney: physiology and pathophysiology, vol 2, chapter 72, pp 2425\u20132456","DOI":"10.1016\/B978-0-12-381462-3.00072-0"},{"key":"516_CR18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/mol.54.2.342","volume":"54","author":"AE Busch","year":"1998","unstructured":"Busch AE, Karbach U, Miska D, Gorboulev V, Akhoundova A, Volk C, Arndt P, Ulzheimer JC, Sonders MS, Baumann C et al (1998) Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol 54:342\u2013352","journal-title":"Mol Pharmacol"},{"key":"516_CR19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1124\/jpet.107.123554","volume":"322","author":"Y Chen","year":"2007","unstructured":"Chen Y, Zhang S, Sorani M, Giacomini KM (2007) Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family. J Pharmacol Exp Ther 322:695\u2013700","journal-title":"J Pharmacol Exp Ther"},{"key":"516_CR20","doi-asserted-by":"publisher","first-page":"9983","DOI":"10.1073\/pnas.1314939111","volume":"111","author":"L Chen","year":"2014","unstructured":"Chen L, Shu Y, Liang X, Chen EC, Yee SW, Zur AA, Li S, Xu L, Keshari KR, Lin MJ et al (2014) OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. Proc Natl Acad Sci U S A 111:9983\u20139988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"516_CR21","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1021\/acs.jmedchem.6b01317","volume":"60","author":"EC Chen","year":"2017","unstructured":"Chen EC, Khuri N, Liang X, Stecula A, Chien HC, Yee SW, Huang Y, Sali A, Giacomini KM (2017) Discovery of competitive and noncompetitive ligands of the organic cation transporter 1 (OCT1; SLC22A1). J Med Chem 60:2685\u20132696","journal-title":"J Med Chem"},{"key":"516_CR22","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/bcp.12476","volume":"78","author":"SK Cho","year":"2014","unstructured":"Cho SK, Kim CO, Park ES, Chung JY (2014) Verapamil decreases the glucose-lowering effect of metformin in healthy volunteers. Br J Clin Pharmacol 78:1426\u20131432. https:\/\/doi.org\/10.1111\/bcp.12476","journal-title":"Br J Clin Pharmacol"},{"key":"516_CR23","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/S0002-9440(10)61234-5","volume":"167","author":"G Ciarimboli","year":"2005","unstructured":"Ciarimboli G, Ludwig T, Lang D, Pavenst\u00e4dt H, Koepsell H, Piechota HJ, Haier J, Jaehde U, Zisowsky J, Schlatter E (2005) Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. Am J Pathol 167:1477\u20131484. https:\/\/doi.org\/10.1016\/S0002-9440(10)61234-5","journal-title":"Am J Pathol"},{"key":"516_CR24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1021\/mp100329u","volume":"8","author":"G Ciarimboli","year":"2011","unstructured":"Ciarimboli G, Holle SK, Vollenbr\u00f6cker B, Hagos Y, Reuter S, Burckhardt G, Bierer S, Herrmann E, Pavenst\u00e4dt H, Rossi R et al (2011) New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2. Mol Pharm 8:270\u2013279","journal-title":"Mol Pharm"},{"key":"516_CR25","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1158\/1078-0432.CCR-11-2503","volume":"18","author":"G Ciarimboli","year":"2012","unstructured":"Ciarimboli G, Lancaster CS, Schlatter E, Franke RM, Sprowl JA, Pavenst\u00e4dt H, Massmann V, Guckel D, Mathijssen RH, Yang W et al (2012) Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients. Clin Cancer Res 18:1101\u20131108","journal-title":"Clin Cancer Res"},{"key":"516_CR26","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1021\/mp4000234","volume":"10","author":"G Ciarimboli","year":"2013","unstructured":"Ciarimboli G, Schr\u00f6ter R, Neugebauer U, Vollenbr\u00f6ker B, Gabri\u00ebls G, Brzica H, Saboli\u0107 I, Pietig G, Pavenst\u00e4dt H, Schlatter E, Edemir B (2013) Kidney transplantation down-regulates expression of organic cation transporters, which translocate \u03b2-blockers and fluoroquinolones. Mol Pharm 10:2370\u20132380","journal-title":"Mol Pharm"},{"key":"516_CR27","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcph.1603","volume":"60","author":"AC Conchon Costa","year":"2020","unstructured":"Conchon Costa AC, Yamamoto PA, Rocha Lauretti G, de Lima Benzi JR, Zanelli CF, Barz V, Ciarimboli G, de Moraes NV (2020) Cetirizine reduces gabapentin plasma concentrations and effect: role of renal drug transporters for organic cations. J Clin Pharmacol 60:1076\u20131086","journal-title":"J Clin Pharmacol"},{"key":"516_CR502","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.neuroscience.2007.01.072","volume":"146","author":"A Dahlin","year":"2007","unstructured":"Dahlin A, Xia L, Kong W, Hevner R, Wang J (2007) Expression and immunolocalization of the plasma membrane monoamine transporter in the brain. Neuroscience 146:1193\u20131211. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.01.072","journal-title":"Neuroscience"},{"key":"516_CR28","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2337\/dc18-2182","volume":"42","author":"AY Dawed","year":"2019","unstructured":"Dawed AY, Zhou K, van Leeuwen N, Mahajan A, Robertson N, Koivula R, Elders PJM, Rauh SP, Jones AG, Holl RW, Stingl JC, Franks PW, McCarthy MI, Leen\u2019t Hart LM, Pearson ER (2019) Variation in the plasma membrane monoamine transporter (PMAT) (encoded by SLC29A4) and organic cation transporter 1 (OCT1) (encoded by SLC22A1) and gastrointestinal intolerance to metformin in type 2 diabetes: an IMI DIRECT study. Diabetes Care 42:1027\u20131033. https:\/\/doi.org\/10.2337\/dc18-2182","journal-title":"Diabetes Care"},{"key":"516_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pharmthera.2008.10.004","volume":"121","author":"LC Daws","year":"2009","unstructured":"Daws LC (2009) Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy. Pharmacol Ther 121:89\u201399. https:\/\/doi.org\/10.1016\/j.pharmthera.2008.10.004","journal-title":"Pharmacol Ther"},{"key":"516_CR30","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1021\/mp100036b","volume":"7","author":"L Diao","year":"2010","unstructured":"Diao L, Shu Y, Polli JE (2010) Uptake of pramipexole by human organic cation transporters. Mol Pharm 7:1342\u20131347","journal-title":"Mol Pharm"},{"key":"516_CR31","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.bcp.2011.12.032","volume":"83","author":"D Dickens","year":"2012","unstructured":"Dickens D, Owen A, Alfirevic A, Giannoudis A, Davies A, Weksler B, Romero IA, Couraud PO, Pirmohamed M (2012) Lamotrigine is a substrate for OCT1 in brain endothelial cells. Biochem Pharmacol 83:805\u2013814","journal-title":"Biochem Pharmacol"},{"key":"516_CR32","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1208\/s12248-014-9649-9","volume":"16","author":"JN Dos Santos Pereira","year":"2014","unstructured":"Dos Santos Pereira JN, Tadjerpisheh S, Abu Abed M, Saadatmand AR, Weksler B, Romero IA, Couraud PO, Brockm\u00f6ller J, Tzvetkov MV (2014) The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family. AAPS J 16:1247\u20131258","journal-title":"AAPS J"},{"key":"516_CR33","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1023\/A:1019870831174","volume":"19","author":"MJ Dresser","year":"2002","unstructured":"Dresser MJ, Xiao G, Leabman MK, Gray AT, Giacomini KM (2002) Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2). Pharm Res 19:1244\u20131247","journal-title":"Pharm Res"},{"key":"516_CR34","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1124\/jpet.110.170142","volume":"335","author":"H Duan","year":"2010","unstructured":"Duan H, Wang J (2010) Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3. J Pharmacol Exp Ther 335:743\u2013753","journal-title":"J Pharmacol Exp Ther"},{"key":"516_CR35","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1124\/dmd.115.064824","volume":"43","author":"H Duan","year":"2015","unstructured":"Duan H, Hu T, Foti RS, Pan Y, Swaan PW, Wang J (2015) Potent and selective inhibition of plasma membrane monoamine transporter by HIV protease inhibitors. Drug Metab Dispos 43:1773\u20131780","journal-title":"Drug Metab Dispos"},{"key":"516_CR36","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/dme.13040","volume":"33","author":"T Dujic","year":"2016","unstructured":"Dujic T, Causevic A, Bego T, Malenica M, Velija-Asimi Z, Pearson ER, Semiz S (2016) Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with type 2 diabetes. Diabet Med 33:511\u2013514. https:\/\/doi.org\/10.1111\/dme.13040","journal-title":"Diabet Med"},{"key":"516_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/s0163-7258(01)00144-9","volume":"91","author":"G Eisenhofer","year":"2001","unstructured":"Eisenhofer G (2001) The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 91:35\u201362. https:\/\/doi.org\/10.1016\/s0163-7258(01)00144-9","journal-title":"Pharmacol Ther"},{"key":"516_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1124\/dmd.117.076554","volume":"46","author":"WEA Ellawatty","year":"2018","unstructured":"Ellawatty WEA, Masuo Y, Fujita KI, Yamazaki E, Ishida H, Arakawa H, Nakamichi N, Abdelwahed R, Sasaki Y, Kato Y (2018) Organic cation transporter 1 is responsible for hepatocellular uptake of the tyrosine kinase inhibitor pazopanib. Drug Metab Dispos 46:33\u201340","journal-title":"Drug Metab Dispos"},{"key":"516_CR39","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1124\/mol.105.016832","volume":"68","author":"K Engel","year":"2005","unstructured":"Engel K, Wang J (2005) Interaction of organic cations with a newly identified plasma membrane monoamine transporter. Mol Pharmacol 68:1397\u20131407","journal-title":"Mol Pharmacol"},{"key":"516_CR40","doi-asserted-by":"publisher","first-page":"50042","DOI":"10.1074\/jbc.M407913200","volume":"279","author":"K Engel","year":"2004","unstructured":"Engel K, Zhou M, Wang J (2004) Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem 279:50042\u201350049. https:\/\/doi.org\/10.1074\/jbc.M407913200","journal-title":"J Biol Chem"},{"key":"516_CR41","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/sj.clpt.6100405","volume":"83","author":"B Feng","year":"2008","unstructured":"Feng B, Obach RS, Burstein AH, Clark DJ, de Morais SM, Faessel HM (2008) Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation: an in vitro-in vivo study. Clin Pharmacol Ther 83:567\u2013576","journal-title":"Clin Pharmacol Ther"},{"key":"516_CR42","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1158\/1078-0432.CCR-07-4793","volume":"14","author":"KK Filipski","year":"2008","unstructured":"Filipski KK, Loos WJ, Verweij J, Sparreboom A (2008) Interaction of cisplatin with the human organic cation transporter 2. Clin Cancer Res 14:3875\u20133880","journal-title":"Clin Cancer Res"},{"key":"516_CR43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ejphar.2018.10.028","volume":"842","author":"R Fraser-Spears","year":"2019","unstructured":"Fraser-Spears R, Krause-Heuer AM, Basiouny M, Mayer FP, Manishimwe R, Wyatt NA, Dobrowolski JC, Roberts MP, Greguric I, Kumar N, Koek W, Sitte HH, Callaghan PD, Fraser BH, Daws LC (2019) Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter. Eur J Pharmacol 842:351\u2013364","journal-title":"Eur J Pharmacol"},{"key":"516_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jchemneu.2017.07.009","volume":"83-84","author":"PJ Gasser","year":"2017","unstructured":"Gasser PJ, Daws LC (2017) Extending the family: roles for uptake2 transporters in regulation of monoaminergic signaling. J Chem Neuroanat 83-84:107\u2013108. https:\/\/doi.org\/10.1016\/j.jchemneu.2017.07.009","journal-title":"J Chem Neuroanat"},{"key":"516_CR45","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/clpt.2013.175","volume":"94","author":"EG Geier","year":"2013","unstructured":"Geier EG, Chen EC, Webb A, Papp AC, Yee SW, Sadee W, Giacomini KM (2013) Profiling solute carrier transporters in the human blood-brain barrier. Clin Pharmacol Ther 94:636\u2013639. https:\/\/doi.org\/10.1038\/clpt.2013.175. Epub 2013 Sep 5","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"516_CR503","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/cpt.1360","volume":"105","author":"A Gessner","year":"2019","unstructured":"Gessner A, K\u00f6nig J, Fromm MF (2019) Clinical Aspects of Transporter-Mediated Drug-Drug Interactions. Clin Pharmacol Ther 105(6):1386\u20131394. https:\/\/doi.org\/10.1002\/cpt.1360. Epub 2019 Mar 18. PMID: 30648735","journal-title":"Clin Pharmacol Ther"},{"key":"516_CR46","doi-asserted-by":"publisher","first-page":"311","DOI":"10.31887\/DCNS.2006.8.3\/fgirardin","volume":"8","author":"F Girardin","year":"2006","unstructured":"Girardin F (2006) Membrane transporter proteins: a challenge for CNS drug development. Dialogues Clin Neurosci 8:311\u2013321. https:\/\/doi.org\/10.31887\/DCNS.2006.8.3\/fgirardin","journal-title":"Dialogues Clin Neurosci"},{"key":"516_CR47","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1089\/dna.1997.16.871","volume":"16","author":"V Gorboulev","year":"1997","unstructured":"Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Busch AE, Koepsell H (1997) Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16:871\u2013881","journal-title":"DNA Cell Biol"},{"key":"516_CR48","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1124\/mol.56.6.1254","volume":"56","author":"V Gorboulev","year":"1999","unstructured":"Gorboulev V, Volk C, Arndt P, Akhoundova A, Koepsell H (1999) Selectivity of the polyspecific cation transporter rOCT1 is changed by mutation of aspartate 475 to glutamate. Mol Pharmacol 56:1254\u20131261. https:\/\/doi.org\/10.1124\/mol.56.6.1254","journal-title":"Mol Pharmacol"},{"key":"516_CR49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12885-016-2150-3","volume":"16","author":"D Grimm","year":"2016","unstructured":"Grimm D, Lieb J, Weyer V, Vollmar J, Darstein F, Lautem A, Hoppe-Lotichius M, Koch S, Schad A, Schattenberg JM, W\u00f6rns MA, Weinmann A, Galle PR, Zimmermann T (2016) Organic cation transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment. BMC Cancer 16:94. https:\/\/doi.org\/10.1186\/s12885-016-2150-3","journal-title":"BMC Cancer"},{"issue":"6506","key":"516_CR50","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/372549a0","volume":"372","author":"D Gr\u00fcndemann","year":"1994","unstructured":"Gr\u00fcndemann D, Gorboulev V, Gambaryan S, Veyhl M (1994) Koepsell H (1994) drug excretion mediated by a new prototype of polyspecific transporter. Nature 372(6506):549\u2013552. https:\/\/doi.org\/10.1038\/372549a0","journal-title":"Nature"},{"key":"516_CR51","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/1557","volume":"1","author":"D Gr\u00fcndemann","year":"1998","unstructured":"Gr\u00fcndemann D, Schechinger B, Rappold GA, Sch\u00f6mig E (1998) Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1:349\u2013351","journal-title":"Nat Neurosci"},{"key":"516_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/mol.56.1.1","volume":"56","author":"D Gr\u00fcndemann","year":"1999","unstructured":"Gr\u00fcndemann D, Liebich G, Kiefer N, K\u00f6ster S, Sch\u00f6mig E (1999) Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol 56:1\u201310","journal-title":"Mol Pharmacol"},{"key":"516_CR53","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1124\/jpet.102.044404","volume":"304","author":"D Gr\u00fcndemann","year":"2003","unstructured":"Gr\u00fcndemann D, Hahne C, Berkels R, Sch\u00f6mig E (2003) Agmatine is efficiently transported by non-neuronal monoamine transporters extraneuronal monoamine transporter (EMT) and organic cation transporter 2 (OCT2). J Pharmacol Exp Ther 304:810\u2013817","journal-title":"J Pharmacol Exp Ther"},{"key":"516_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1124\/jpet.111.190561","volume":"341","author":"S Gupta","year":"2012","unstructured":"Gupta S, Wulf G, Henjakovic M, Koepsell H, Burckhardt G, Hagos Y (2012) Human organic cation transporter 1 is expressed in lymphoma cells and increases susceptibility to irinotecan and paclitaxel. J Pharmacol Exp Ther 341:16\u201323","journal-title":"J Pharmacol Exp Ther"},{"key":"516_CR55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00210-009-0479-8","volume":"57","author":"B Haenisch","year":"2010","unstructured":"Haenisch B, B\u00f6nisch H (2010) Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics. Naunyn Schmiedebergs Arch Pharmacol 57:33\u201339","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"516_CR56","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00213-011-2281-9","volume":"217","author":"B Haenisch","year":"2011","unstructured":"Haenisch B, Hiemke C, B\u00f6nisch H (2011) Inhibitory potencies of trimipramine and its main metabolites at human monoamine and organic cation transporters. Psychopharmacology (Berl) 217:289\u2013295","journal-title":"Psychopharmacology (Berl)"},{"key":"516_CR57","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00210-012-0781-8","volume":"385","author":"B Haenisch","year":"2012","unstructured":"Haenisch B, Drescher E, Thiemer L, Xin H, Giros B, Gautron S, B\u00f6nisch H (2012) Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3. Naunyn Schmiedebergs Arch Pharmacol 385:1017\u20131023","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"516_CR58","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/mol.112.084517","volume":"84","author":"TK Han","year":"2013","unstructured":"Han TK, Everett RS, Proctor WR, Ng CM, Costales CL, Brouwer KL, Thakker DR (2013) Organic cation transporter 1 (OCT1\/mOct1) is localized in the apical membrane of Caco-2 cell monolayers and enterocytes. Mol Pharmacol 84:182\u2013189. https:\/\/doi.org\/10.1124\/mol.112.084517","journal-title":"Mol Pharmacol"},{"key":"516_CR59","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/pl00005261","volume":"358","author":"K Hara","year":"1998","unstructured":"Hara K, Yanagihara N, Minami K, Ueno S, Toyohira Y, Sata T, Kawamura M, Br\u00fcss M, B\u00f6nisch H, Shigematsu A, Izumi F (1998) Ketamine interacts with the noradrenaline transporter at a site partly overlapping the desipramine binding site. Naunyn Schmiedebergs Arch Pharmacol 358:328\u2013333. https:\/\/doi.org\/10.1007\/pl00005261","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1\u20132","key":"516_CR600","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejphar.2004.07.098","volume":"499","author":"H Hasannejad","year":"2004","unstructured":"Hasannejad H, Takeda M, Narikawa S, Huang X-L, Enomoto A, Taki K, Niwa T, Jung SH, Onozato ML, Tojo A, Endou H (2004) Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs. Eur J Pharmacol 499(1\u20132):45\u201351. https:\/\/doi.org\/10.1016\/j.ejphar.2004.07.098. PMID: 15363950","journal-title":"Eur J Pharmacol"},{"key":"516_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejphar.2004.07.098","volume":"499","author":"H Hasannejad","year":"2009","unstructured":"Hasannejad H, Takeda M, Narikawa S, Huang X-L, Enomoto A, Taki K, Niwa T, Jung SH, Onozato ML, Tojo A et al (2009) Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs. Eur J Pharmacol 499:45\u201351","journal-title":"Eur J Pharmacol"},{"key":"516_CR61","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/sj.bjp.0704785","volume":"136","author":"M Hayer-Zillgen","year":"2002","unstructured":"Hayer-Zillgen M, Br\u00fcss M, B\u00f6nisch H (2002) Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br J Pharmacol 136:829\u2013836","journal-title":"Br J Pharmacol"},{"key":"516_CR62","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0014-2999(70)90062-2","volume":"12","author":"ED Hendley","year":"1970","unstructured":"Hendley ED, Taylor KM, Snyder SH (1970) 3H-normetanephrine uptake in rat brain slices. Relationship to extraneuronal accumulation of norepinephrine. Eur J Pharmacol 12:167\u2013179. https:\/\/doi.org\/10.1016\/0014-2999(70)90062-2","journal-title":"Eur J Pharmacol"},{"key":"516_CR63","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.1021\/jm400966v","volume":"56","author":"R Hendrickx","year":"2013","unstructured":"Hendrickx R, Johansson JG, Lohmann C, Jenvert RM, Blomgren A, B\u00f6rjesson L, Gustavsson L (2013) Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem 56:7232\u20137242","journal-title":"J Med Chem"},{"key":"516_CR64","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fphar.2012.00154","volume":"3","author":"HT Ho","year":"2012","unstructured":"Ho HT, Dahlin A, Wang J (2012) Expression profiling of solute carrier gene families at the blood-CSF barrier. Front Pharmacol 3:154. https:\/\/doi.org\/10.3389\/fphar.2012.00154. eCollection 2012","journal-title":"Front Pharmacol"},{"key":"516_CR65","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/clpt.2010.232","volume":"89","author":"Y Imamura","year":"2011","unstructured":"Imamura Y, Murayama N, Okudaira N, Kurihara A, Okazaki O, Izumi T, Inoue K, Yuasa H, Kusuhara H, Sugiyama Y (2011) Prediction of fluoroquinoloneinduced elevation in serum creatinine levels: a case of drug-endogenous substance interaction involving the inhibition of renal secretion. Clin Pharmacol Ther 89:81\u201388","journal-title":"Clin Pharmacol Ther"},{"key":"516_CR66","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1124\/dmd.104.002519","volume":"33","author":"N Ishiguro","year":"2005","unstructured":"Ishiguro N, Saito A, Yokoyama K, Morikawa M, Igarashi T, Tamai I (2005) Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney. Drug Metab Dispos 33:495\u2013499. https:\/\/doi.org\/10.1124\/dmd.104.002519. Epub 2005 Jan 7","journal-title":"Drug Metab Dispos"},{"key":"516_CR67","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1124\/jpet.111.184986","volume":"340","author":"S Ito","year":"2012","unstructured":"Ito S, Kusuhara H, Yokochi M, Toyoshima J, Inoue K, Yuasa H, Sugiyama Y (2012) Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney. J Pharmacol Exp Ther 340:393\u2013403","journal-title":"J Pharmacol Exp Ther"},{"key":"516_CR68","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s40262-017-0506-8","volume":"56","author":"A Ivanyuk","year":"2017","unstructured":"Ivanyuk A, Livio F, Biollaz J, Buclin T (2017) Renal drug transporters and drug interactions. Clin Pharmacokinet 56:825\u2013892. https:\/\/doi.org\/10.1007\/s40262-017-0506-8","journal-title":"Clin Pharmacokinet"},{"key":"516_CR69","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1476-5381.1965.tb01753.x","volume":"25","author":"LL Iversen","year":"1965","unstructured":"Iversen LL (1965) The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: a novel catechol amine uptake process. Br J Pharmacol Chemother 25:18\u201333. https:\/\/doi.org\/10.1111\/j.1476-5381.1965.tb01753.x","journal-title":"Br J Pharmacol Chemother"},{"issue":"4","key":"516_CR504","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1476-5381.1971.tb07066.x","volume":"41","author":"LL Iversen","year":"1971","unstructured":"Iversen LL (1971) Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol 41(4):571\u2013591. https:\/\/doi.org\/10.1111\/j.1476-5381.1971.tb07066.x. PMID: 4397129","journal-title":"Br J Pharmacol"},{"key":"516_CR70","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/oxfordjournals.bmb.a070982","volume":"29","author":"LL Iversen","year":"1973","unstructured":"Iversen LL (1973) Catecholamine uptake processes. Br Med Bull 29:130\u2013135. https:\/\/doi.org\/10.1093\/oxfordjournals.bmb.a070982","journal-title":"Br Med Bull"},{"key":"516_CR71","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1476-5381.1972.tb06890.x","volume":"46","author":"LL Iversen","year":"1972","unstructured":"Iversen LL, Salt PJ, Wilson HA (1972) Inhibition of catecholamine uptake in the isolated rat heart by haloalkylamines related to phenoxybenzamine. Br J Pharmacol 46:647\u2013657. https:\/\/doi.org\/10.1111\/j.1476-5381.1972.tb06890.x","journal-title":"Br J Pharmacol"},{"key":"516_CR72","doi-asserted-by":"publisher","first-page":"609811","DOI":"10.3389\/fphar.2020.609811","volume":"11","author":"O Jensen","year":"2021","unstructured":"Jensen O, Rafehi M, Gebauer L, Brockm\u00f6ller J (2021) Cellular uptake of psychostimulants \u2013 are high- and low-affinity organic cation transporters drug traffickers? Front Pharmacol 11:609811. https:\/\/doi.org\/10.3389\/fphar.2020.609811. eCollection 2020","journal-title":"Front Pharmacol"},{"key":"516_CR73","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1124\/dmd.108.020826","volume":"36","author":"N Jung","year":"2008","unstructured":"Jung N, Lehmann C, Rubbert A, Knispel M, Hartmann P, van Lunzen J, Stellbrink HJ, Faetkenheuer G, Taubert D (2008) Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection. Drug Metab Dispos 36:1616\u20131623","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"516_CR505","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3350\/kjhep.2009.15.1.52","volume":"15","author":"HW Jung","year":"2009","unstructured":"Jung HW, Choi MS, Kim KH, Park SH, Yeon KK, Lee JH, Koh KC, Paik SW, Yoo BC (2009) Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, lamivudine-resistant chronic hepatitis B patients. Korean J Hepatol 15(1):52\u201358. https:\/\/doi.org\/10.3350\/kjhep.2009.15.1.52. PMID: 19346785","journal-title":"Korean J Hepatol"},{"key":"516_CR74","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s15010-012-0308-8","volume":"41","author":"N Jung","year":"2013","unstructured":"Jung N, Lehmann C, Rubbert A, Sch\u00f6mig E, F\u00e4tkenheuer G, Hartmann P, Taubert D (2013) Organic cation transporters OCT1 and OCT2 determine the accumulation of lamivudine in CD4 cells of HIV-infected patients. Infection 41:379\u2013385. https:\/\/doi.org\/10.1007\/s15010-012-0308-8. Epub 2012 Aug 9","journal-title":"Infection"},{"key":"516_CR75","doi-asserted-by":"publisher","first-page":"15971","DOI":"10.1074\/jbc.273.26.15971","volume":"273","author":"R Kekuda","year":"1998","unstructured":"Kekuda R, Prasad PD, Wu X, Wang H, Fei YJ, Leibach FH, Ganapathy V (1998) Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 273:15971\u201315979. https:\/\/doi.org\/10.1074\/jbc.273.26.15971","journal-title":"J Biol Chem"},{"key":"516_CR76","doi-asserted-by":"publisher","first-page":"12253","DOI":"10.1021\/bi050676c","volume":"44","author":"T Keller","year":"2005","unstructured":"Keller T, Elfeber M, Gorboulev V, Reil\u00e4nder H, Koepsell H (2005) Purification and functional reconstitution of the rat organic cation transporter OCT1. Biochemistry 44:12253\u201312263. https:\/\/doi.org\/10.1021\/bi050676c","journal-title":"Biochemistry"},{"key":"516_CR77","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1021\/jm2001629","volume":"54","author":"Y Kido","year":"2011","unstructured":"Kido Y, Matsson P, Giacomini KM (2011) Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. J Med Chem 54:4548\u20134558","journal-title":"J Med Chem"},{"key":"516_CR78","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.1002\/jps.23737","volume":"102","author":"R Kikuchi","year":"2013","unstructured":"Kikuchi R, Lao Y, Bow DA, Chiou WJ, Andracki ME, Carr RA, Voorman RL, De Morais SM (2013) Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K). J Pharm Sci 102:4426\u20134432","journal-title":"J Pharm Sci"},{"key":"516_CR79","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1124\/dmd.113.055616","volume":"42","author":"A Kim","year":"2014","unstructured":"Kim A, Chung I, Yoon SH, Yu KS, Lim KS, Cho JY, Lee H, Jang IJ, Chung JY (2014) Effects of proton pump inhibitors on metformin pharmacokinetics and pharmacodynamics. Drug Metab Dispos 42:1174\u20131179. https:\/\/doi.org\/10.1124\/dmd.113.055616. Epub 2014 Apr 24","journal-title":"Drug Metab Dispos"},{"key":"516_CR80","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1515\/BC.2011.009","volume":"392","author":"H Koepsell","year":"2011","unstructured":"Koepsell H (2011) Substrate recognition and translocation by polyspecific organic cation transporters. Biol Chem 392:95\u2013101. https:\/\/doi.org\/10.1515\/BC.2011.009","journal-title":"Biol Chem"},{"key":"516_CR81","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1517\/17425255.2015.1069274","volume":"11","author":"H Koepsell","year":"2015","unstructured":"Koepsell H (2015) Role of organic cation transporters in drug-drug interaction. Expert Opin Drug Metab Toxicol 11:1619\u20131633. https:\/\/doi.org\/10.1517\/17425255.2015.1069274. Epub 2015 Jul 24","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"516_CR82","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1515\/hsz-2018-0191","volume":"400","author":"H Koepsell","year":"2019","unstructured":"Koepsell H (2019) Multiple binding sites in organic cation transporters require sophisticated procedures to identify interactions of novel drugs. Biol Chem 400:195\u2013207. https:\/\/doi.org\/10.1515\/hsz-2018-0191","journal-title":"Biol Chem"},{"key":"516_CR83","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1124\/pr.118.015578","volume":"72","author":"H Koepsell","year":"2020","unstructured":"Koepsell H (2020) Organic cation transporters in health and disease. Pharmacol Rev 72:253\u2013319","journal-title":"Pharmacol Rev"},{"key":"516_CR84","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s10254-003-0017-x","volume":"150","author":"H Koepsell","year":"2003","unstructured":"Koepsell H, Schmitt BM, Gorboulev V (2003) Organic cation transporters. Rev Physiol Biochem Pharmacol 150:36\u201390. https:\/\/doi.org\/10.1007\/s10254-003-0017-x. Epub 2003 Jun 25","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"516_CR85","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","volume":"24","author":"H Koepsell","year":"2007","unstructured":"Koepsell H, Lips K, Volk C (2007) Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 24:1227\u20131251","journal-title":"Pharm Res"},{"key":"516_CR86","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1385\/JMN:30:1:67","volume":"30","author":"W Kummer","year":"2006","unstructured":"Kummer W, Wiegand S, Akinci S, Schinkel AH, Wess J, Koepsell H, Haberberger RV, Lips KS (2006) Role of acetylcholine and muscarinic receptors in serotonin-induced bronchoconstriction in the mouse. J Mol Neurosci 30:67\u201368. https:\/\/doi.org\/10.1385\/JMN:30:1:67","journal-title":"J Mol Neurosci"},{"key":"516_CR87","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/BF02574771","volume":"13","author":"LS Lashford","year":"1988","unstructured":"Lashford LS, Moyes J, Ott R, Fielding S, Babich J, Mellors S, Gordon I, Evans K, Kemshead JT (1988) The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastoma. Eur J Nucl Med 13:574\u2013577. https:\/\/doi.org\/10.1007\/BF02574771","journal-title":"Eur J Nucl Med"},{"key":"516_CR88","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/ki.2014.66","volume":"86","author":"EI Lepist","year":"2014","unstructured":"Lepist EI, Zhang X, Hao J, Huang J, Kosaka A, Birkus G, Murray BP, Bannister R, Cihlar T, Huang Y et al (2014) Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat. Kidney Int 86:350\u2013357","journal-title":"Kidney Int"},{"issue":"2","key":"516_CR89","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/jps.10534","volume":"93","author":"Q Li","year":"2004","unstructured":"Li Q, Sai Y, Kato Y, Muraoka H, Tamai I, Tsuji A (2004) Transporter-mediated renal handling of nafamostat mesilate. J Pharm Sci 93(2):262\u2013272. https:\/\/doi.org\/10.1002\/jps.10534. PMID: 14705184","journal-title":"J Pharm Sci"},{"key":"516_CR90","doi-asserted-by":"publisher","unstructured":"Li X, Sun X, Chen J, Lu Y, Zhang Y, Wang C, Li J, Zhang Q, Zhao D, Chen X (2015) Investigation of the role of organic cation transporter 2 (OCT2) in the renal transport of guanfacine, a selective alpha2A-adrenoreceptor agonist. Xenobiotica 45(1):88\u201394. https:\/\/doi.org\/10.3109\/00498254.2014.949904. Epub 2014 Aug 13. PMID: 25115365","DOI":"10.3109\/00498254.2014.949904"},{"key":"516_CR91","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/bdd.2104","volume":"38","author":"L Li","year":"2017","unstructured":"Li L, Weng Y, Wang W, Bai M, Lei H, Zhou H, Jiang H (2017) Multiple organic cation transporters contribute to the renal transport of sulpiride. Biopharm Drug Dispos 38:526\u2013534","journal-title":"Biopharm Drug Dispos"},{"key":"516_CR92","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1471-4159.2010.06801.x","volume":"114","author":"CJ Lin","year":"2010","unstructured":"Lin CJ, Tai Y, Huang MT, Tsai YF, Hsu HJ, Tzen KY, Liou HH (2010) Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents. J Neurochem 114:717\u2013727. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06801.x. Epub 2010 May 6","journal-title":"J Neurochem"},{"key":"516_CR93","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1165\/rcmb.2004-0363OC","volume":"33","author":"KS Lips","year":"2005","unstructured":"Lips KS, Volk C, Schmitt BM, Pfeil U, Arndt P, Miska D, Ermert L, Kummer W, Koepsell H (2005) Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium. Am J Respir Cell Mol Biol 33:79\u201388","journal-title":"Am J Respir Cell Mol Biol"},{"key":"516_CR94","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/978-981-13-7647-4_9","volume":"1141","author":"L Liu","year":"2019","unstructured":"Liu L, Liu X (2019) Contributions of drug transporters to blood-brain barriers. Adv Exp Med Biol 1141:407\u2013466. https:\/\/doi.org\/10.1007\/978-981-13-7647-4_9","journal-title":"Adv Exp Med Biol"},{"key":"516_CR95","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1124\/mol.120.119495","volume":"98","author":"AJ L\u00f3pez Qui\u00f1ones","year":"2020","unstructured":"L\u00f3pez Qui\u00f1ones AJ, Wagner DJ, Wang J (2020) Characterization of meta-Iodobenzylguanidine (mIBG) transport by polyspecific organic cation transporters: implication for mIBG therapy. Mol Pharmacol 98:109\u2013119","journal-title":"Mol Pharmacol"},{"key":"516_CR96","doi-asserted-by":"publisher","first-page":"692071","DOI":"10.1155\/2013\/692071","volume":"2013","author":"E Lozano","year":"2013","unstructured":"Lozano E, Herraez E, Briz O, Robledo VS, Hernandez-Iglesias J, Gonzalez-Hernandez A, Marin JJ (2013) Role of the plasma membrane transporter of organic cations OCT1 and its genetic variants in modern liver pharmacology. Biomed Res Int 2013:692071. https:\/\/doi.org\/10.1155\/2013\/692071. Epub 2013 Jul 31","journal-title":"Biomed Res Int"},{"key":"516_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00499868","volume":"310","author":"F Mack","year":"1979","unstructured":"Mack F, B\u00f6nisch H (1979) Dissociation constants and lipophilicity of catecholamines and related compounds. Naunyn Schmiedebergs Arch Pharmacol 310:1\u20139. https:\/\/doi.org\/10.1007\/BF00499868","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"516_CR98","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00424-013-1335-8","volume":"466","author":"V Massmann","year":"2014","unstructured":"Massmann V, Edemir B, Schlatter E, Al-Monajjed R, Harrach S, Klassen P, Holle SK, Sindic A, Dobrivojevic M, Pavenst\u00e4dt H et al (2014) The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3. Pflugers Arch 466:517\u2013527","journal-title":"Pflugers Arch"},{"key":"516_CR506","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1038\/s41386-018-0053-5","volume":"43","author":"FP Mayer","year":"2018","unstructured":"Mayer FP, Schmid D, Owens WA, Gould GG, Apuschkin M, Kudlacek O, Salzer I, Boehm S, Chiba P, Williams PH, Wu HH, Gether U, Koek W, Daws LC, Sitte HH (2018) An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Neuropsychopharmacology 43:2408\u20132417. https:\/\/doi.org\/10.1038\/s41386-018-0053-5","journal-title":"Neuropsychopharmacology"},{"key":"516_CR99","doi-asserted-by":"publisher","first-page":"e0189521","DOI":"10.1371\/journal.pone.0189521","volume":"12","author":"MJ Meyer","year":"2017","unstructured":"Meyer MJ, Seitz T, Brockm\u00f6ller J, Tzvetkov MV (2017) Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine. PLoS One 12:e0189521. https:\/\/doi.org\/10.1371\/journal.pone.0189521","journal-title":"PLoS One"},{"key":"516_CR100","doi-asserted-by":"publisher","first-page":"9890","DOI":"10.1021\/acs.jmedchem.9b01301","volume":"62","author":"MJ Meyer","year":"2019","unstructured":"Meyer MJ, Neumann VE, Friesacher HR, Zdrazil B, Brockm\u00f6ller J, Tzvetkov MV (2019) Opioids as substrates and inhibitors of the genetically highly variable organic cation transporter OCT1. J Med Chem 62:9890\u20139905. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01301. Epub 2019 Nov 4","journal-title":"J Med Chem"},{"key":"516_CR101","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1158\/1535-7163.MCT-10-0731","volume":"10","author":"T Minematsu","year":"2011","unstructured":"Minematsu T, Giacomini KM (2011) Interactions of tyrosine kinase inhibitors with organic cation transporters and multidrug and toxic compound extrusion proteins. Mol Cancer Ther 10:531\u2013539","journal-title":"Mol Cancer Ther"},{"key":"516_CR102","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1124\/jpet.108.146225","volume":"329","author":"G Minuesa","year":"2009","unstructured":"Minuesa G, Volk C, Molina-Arcas M, Gorboulev V, Erkizia I, Arndt P, Clotet B, Pastor-Anglada M, Koepsell H, Martinez-Picado J (2009) Transport of lamivudine [(\u2212)-b-L-29,39-dideoxy-39-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3. J Pharmacol Exp Ther 329:252\u2013261","journal-title":"J Pharmacol Exp Ther"},{"key":"516_CR103","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.pharmthera.2011.06.007","volume":"132","author":"G Minuesa","year":"2011","unstructured":"Minuesa G, Huber-Ruano I, Pastor-Anglada M, Koepsell H, Clotet B, Martinez-Picado J (2011) Drug uptake transporters in antiretroviral therapy. Pharmacol Ther 132:268\u2013279","journal-title":"Pharmacol Ther"},{"key":"516_CR104","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1021\/acs.molpharmaceut.5b00733","volume":"13","author":"S Misaka","year":"2016","unstructured":"Misaka S, Knop J, Singer K, Hoier E, Keiser M, M\u00fcller F, Glaeser H, K\u00f6nig J, Fromm MF (2016) The nonmetabolized b-blocker nadolol is a substrate of OCT1, OCT2, MATE1, MATE2-K, and P-glycoprotein, but not of OATP1B1 and OATP1B3. Mol Pharm 13:512\u2013519","journal-title":"Mol Pharm"},{"key":"516_CR105","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/2211-5463.12183","volume":"7","author":"Y Miura","year":"2017","unstructured":"Miura Y, Yoshikawa T, Naganuma F, Nakamura T, Iida T, K\u00e1rp\u00e1ti A, Matsuzawa T, Mogi A, Harada R, Yanai K (2017) Characterization of murine polyspecific monoamine transporters. FEBS Open Bio 7:237\u2013248. https:\/\/doi.org\/10.1002\/2211-5463.12183. eCollection 2017 Feb","journal-title":"FEBS Open Bio"},{"key":"516_CR106","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1158\/1535-7163.MCT-09-1084","volume":"9","author":"SS More","year":"2010","unstructured":"More SS, Li S, Yee SW, Chen L, Xu Z, Jablons DM, Giacomini KM (2010) Organic cation transporters modulate the uptake and cytotoxicity of picoplatin, a third-generation platinum analogue. Mol Cancer Ther 9:1058\u20131069","journal-title":"Mol Cancer Ther"},{"key":"516_CR107","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1158\/0008-5472.CAN-10-0694","volume":"70","author":"CJ Morrow","year":"2010","unstructured":"Morrow CJ, Ghattas M, Smith C, B\u00f6nisch H, Bryce RA, Hickinson DM, Green TP, Dive C (2010) Src family kinase inhibitor Saracatinib (AZD0530) impairs oxaliplatin uptake in colorectal cancer cells and blocks organic cation transporters. Cancer Res 70:5931\u20135941","journal-title":"Cancer Res"},{"key":"516_CR108","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1128\/AAC.01421-13","volume":"57","author":"DM Moss","year":"2013","unstructured":"Moss DM, Liptrott NJ, Curley P, Siccardi M, Back DJ, Owen A (2013) Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro. Antimicrob Agents Chemother 57:5612\u20135618","journal-title":"Antimicrob Agents Chemother"},{"key":"516_CR109","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejphar.2004.09.032","volume":"503","author":"H Motohashi","year":"2004","unstructured":"Motohashi H, Uwai Y, Hiramoto K, Okuda M, Inui K (2004) Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A). Eur J Pharmacol 503:25\u201330","journal-title":"Eur J Pharmacol"},{"key":"516_CR110","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.bcp.2005.09.011","volume":"70","author":"J M\u00fcller","year":"2005","unstructured":"M\u00fcller J, Lips KS, Metzner L, Neubert RHH, Koepsell H, Brandsch M (2005) Drug specificity and intestinal membrane localization of human organic cation transporters (OCT). Biochem Pharmacol 70:1851\u20131860","journal-title":"Biochem Pharmacol"},{"key":"516_CR111","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1515\/hsz-2016-0259","volume":"398","author":"J M\u00fcller","year":"2017","unstructured":"M\u00fcller J, Keiser M, Drozdzik M, Oswald S (2017) Expression, regulation and function of intestinal drug transporters: an update. Biol Chem 398:175\u2013192. https:\/\/doi.org\/10.1515\/hsz-2016-0259","journal-title":"Biol Chem"},{"key":"516_CR112","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00210-007-0219-x","volume":"376","author":"AT Nies","year":"2008","unstructured":"Nies AT, Herrmann E, Brom M, Keppler D (2008) Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1). Naunyn Schmiedebergs Arch Pharmacol 376:449\u2013461","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"516_CR113","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/hep.23103","volume":"50","author":"AT Nies","year":"2009","unstructured":"Nies AT, Koepsell H, Winter S, Burk O, Klein K, Kerb R, Zanger UM, Keppler D, Schwab M, Schaeffeler E (2009) Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. Hepatology 50:1227\u20131240. https:\/\/doi.org\/10.1002\/hep.23103","journal-title":"Hepatology"},{"key":"516_CR114","doi-asserted-by":"publisher","first-page":"e22163","DOI":"10.1371\/journal.pone.0022163","volume":"6","author":"AT Nies","year":"2011","unstructured":"Nies AT, Hofmann U, Resch C, Schaeffeler E, Rius M, Schwab M (2011) Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs). PLoS One 6:e22163","journal-title":"PLoS One"},{"key":"516_CR115","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2133\/dmpk.20.452","volume":"20","author":"M Nishimura","year":"2005","unstructured":"Nishimura M, Naito S (2005) Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab Pharmacokinet 20:452\u2013477. https:\/\/doi.org\/10.2133\/dmpk.20.452","journal-title":"Drug Metab Pharmacokinet"},{"key":"516_CR116","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1006\/bbrc.1996.1056","volume":"224","author":"M Okuda","year":"1996","unstructured":"Okuda M, Saito H, Urakami Y, Takano M, Inui K (1996) cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem Biophys Res Commun 224:500\u2013507. https:\/\/doi.org\/10.1006\/bbrc.1996.1056","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"516_CR507","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1002\/jps.22594","volume":"100","author":"T Okura","year":"2011","unstructured":"Okura T, Kato S, Takano Y, Sato T, Yamashita A, Morimoto R, Ohtsuki S, Terasaki T, Deguchi Y (2011) Functional characterization of rat plasma membrane monoamine transporter in the blood-brain and blood-cerebrospinal fluid barriers. J Pharm Sci 100(9):3924\u20133938. https:\/\/doi.org\/10.1002\/jps.22594. PMID: 21538354","journal-title":"J Pharm Sci"},{"key":"516_CR117","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/350350a0","volume":"350","author":"T Pacholczyk","year":"1991","unstructured":"Pacholczyk T, Blakely RD, Amara SG (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350:350\u2013354","journal-title":"Nature"},{"key":"516_CR118","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/978-981-13-7647-4_6","volume":"1141","author":"G Pan","year":"2019","unstructured":"Pan G (2019) Roles of hepatic drug transporters in drug disposition and liver toxicity. Adv Exp Med Biol 1141:293\u2013340. https:\/\/doi.org\/10.1007\/978-981-13-7647-4_6","journal-title":"Adv Exp Med Biol"},{"key":"516_CR119","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1128\/AAC.01255-13","volume":"57","author":"X Pan","year":"2013","unstructured":"Pan X, Wang L, Gr\u00fcndemann D, Sweet DH (2013) Interaction of ethambutol with human organic cation transporters of the SLC22 family indicates potential for drug-drug interactions during antituberculosis therapy. Antimicrob Agents Chemother 57:5053\u20135059","journal-title":"Antimicrob Agents Chemother"},{"key":"516_CR120","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1124\/dmd.116.072066","volume":"44","author":"B Prasad","year":"2016","unstructured":"Prasad B, Johnson K, Billington S, Lee C, Chung GW, Brown CD, Kelly EJ, Himmelfarb J, Unadkat JD (2016) Abundance of drug transporters in the human kidney cortex as quantified by quantitative targeted proteomics. Drug Metab Dispos 44:1920\u20131924. https:\/\/doi.org\/10.1124\/dmd.116.072066. Epub 2016 Sep 12","journal-title":"Drug Metab Dispos"},{"key":"516_CR121","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/BF00165297","volume":"346","author":"H Russ","year":"1992","unstructured":"Russ H, Gliese M, Sonna J, Sch\u00f6mig E (1992) The extraneuronal transport mechanism for noradrenaline (uptake2) avidly transports 1-methyl-4-phenylpyridinium (MPP+). Naunyn Schmiedebergs Arch Pharmacol 346:158\u2013165. https:\/\/doi.org\/10.1007\/BF00165297","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"516_CR122","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/BF00173203","volume":"348","author":"H Russ","year":"1993","unstructured":"Russ H, Sonna J, Keppler K, Baunach S, Sch\u00f6mig E (1993) Cyanine-related compounds: a novel class of potent inhibitors of extraneuronal noradrenaline transport. Naunyn Schmiedebergs Arch Pharmacol 348:458\u2013465. https:\/\/doi.org\/10.1007\/BF00173203","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"516_CR123","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/j.1460-9568.1996.tb01294.x","volume":"8","author":"H Russ","year":"1996","unstructured":"Russ H, Staust K, Martel F, Gliese M, Schomig E (1996) The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Eur J Neurosci 8:1256\u20131264","journal-title":"Eur J Neurosci"},{"key":"516_CR124","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/00498254.2017.1328148","volume":"48","author":"M Saidijam","year":"2018","unstructured":"Saidijam M, Karimi Dermani F, Sohrabi S, Patching SG (2018) Efflux proteins at the blood-brain barrier: review and bioinformatics analysis. Xenobiotica 48:506\u2013532. https:\/\/doi.org\/10.1080\/00498254.2017.1328148. Epub 2017 May 30","journal-title":"Xenobiotica"},{"key":"516_CR125","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1021\/mp400024d","volume":"10","author":"M Sala-Rabanal","year":"2013","unstructured":"Sala-Rabanal M, Li DC, Dake GR, Kurata HT, Inyushin M, Skatchkov SN, Nichols CG (2013) Polyamine transport by the polyspecific organic cation transporters OCT1, OCT2, and OCT3. Mol Pharm 10:1450\u20131458","journal-title":"Mol Pharm"},{"key":"516_CR126","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1021\/mp500854e","volume":"12","author":"JJ Salomon","year":"2015","unstructured":"Salomon JJ, Hagos Y, Petzke S, K\u00fchne A, Gausterer JC, Hosoya K, Ehrhardt C (2015) Beta-2 adrenergic agonists are substrates and inhibitors of human organic cation transporter 1. Mol Pharm 12:2633\u20132641","journal-title":"Mol Pharm"},{"issue":"3","key":"516_CR127","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0014-2999(72)90194-x","volume":"20","author":"PJ Salt","year":"1972","unstructured":"Salt PJ (1972) Inhibition of noradrenaline uptake 2 in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines. Eur J Pharmacol 20(3):329\u2013340. https:\/\/doi.org\/10.1016\/0014-2999(72)90194-x","journal-title":"Eur J Pharmacol"},{"key":"516_CR128","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1124\/mol.117.111443","volume":"94","author":"PJ Sandoval","year":"2018","unstructured":"Sandoval PJ, Zorn KM, Clark AM, Ekins S, Wright SH (2018) Assessment of substrate-dependent ligand interactions at the organic cation transporter OCT2 using six model substrates. Mol Pharmacol 94:1057\u20131068","journal-title":"Mol Pharmacol"},{"key":"516_CR129","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/BF00176331","volume":"341","author":"E Sch\u00f6mig","year":"1990","unstructured":"Sch\u00f6mig E, Sch\u00f6nfeld CL (1990) Extraneuronal noradrenaline transport (uptake2) in a human cell line (Caki-1 cells). Naunyn Schmiedebergs Arch Pharmacol 341:404\u2013410. https:\/\/doi.org\/10.1007\/BF00176331","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"516_CR130","doi-asserted-by":"publisher","first-page":"e0173474","DOI":"10.1371\/journal.pone.0173474","volume":"12","author":"GN Sekhar","year":"2017","unstructured":"Sekhar GN, Georgian AR, Sanderson L, Vizcay-Barrena G, Brown RC, Muresan P, Fleck RA, Thomas SA (2017) Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB). PLoS One 12:e0173474. https:\/\/doi.org\/10.1371\/journal.pone.0173474. eCollection 2017","journal-title":"PLoS One"},{"key":"516_CR131","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12987-019-0158-1","volume":"16","author":"GN Sekhar","year":"2019","unstructured":"Sekhar GN, Fleckney AL, Boyanova ST, Rupawala H, Lo R, Wang H, Farag DB, Rahman KM, Broadstock M, Reeves S, Thomas SA (2019) Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer's disease. Fluids Barriers CNS 16:38. https:\/\/doi.org\/10.1186\/s12987-019-0158-1","journal-title":"Fluids Barriers CNS"},{"key":"516_CR132","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/jpet.117.242552","volume":"362","author":"AC Severance","year":"2017","unstructured":"Severance AC, Sandoval PJ, Wright SH (2017) Correlation between apparent substrate affinity and OCT2 transport turnover. J Pharmacol Exp Ther 362:405\u2013412","journal-title":"J Pharmacol Exp Ther"},{"key":"516_CR133","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1158\/0008-5472.CAN-08-2483","volume":"69","author":"V Shnitsar","year":"2009","unstructured":"Shnitsar V, Eckardt R, Gupta S, Grottker J, M\u00fcller GA, Koepsell H, Burckhardt G, Hagos Y (2009) Expression of human organic cation transporter 3 in kidney carcinoma cell lines increases chemosensitivity to melphalan, irinotecan, and vincristine. Cancer Res 69:1494\u20131501","journal-title":"Cancer Res"},{"key":"516_CR134","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/FJC.0b013e3182270783","volume":"58","author":"TF Solbach","year":"2011","unstructured":"Solbach TF, Grube M, Fromm MF, Zolk O (2011) Organic cation transporter 3: expression in failing and nonfailing human heart and functional characterization. J Cardiovasc Pharmacol 58:409\u2013417","journal-title":"J Cardiovasc Pharmacol"},{"key":"516_CR135","doi-asserted-by":"publisher","first-page":"11199","DOI":"10.1073\/pnas.1305321110","volume":"110","author":"JA Sprowl","year":"2013","unstructured":"Sprowl JA, Ciarimboli G, Lancaster CS, Giovinazzo H, Gibson AA, Du G, Janke LJ, Cavaletti G, Shields AF, Sparreboom A (2013) Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2. Proc Natl Acad Sci U S A 110:11199\u201311204","journal-title":"Proc Natl Acad Sci U S A"},{"key":"516_CR136","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000154796","volume":"6","author":"A Stachon","year":"1996","unstructured":"Stachon A, Schlatter E, Hohage H (1996) Dynamic monitoring of organic cation transport processes by fluorescence measurements in LLC-PK1 cells. Cell Physiol Biochem 6:72\u201381. https:\/\/doi.org\/10.1159\/000154796","journal-title":"Cell Physiol Biochem"},{"key":"516_CR137","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/pbc.25200","volume":"62","author":"KA Streby","year":"2015","unstructured":"Streby KA, Shah N, Ranalli MA, Kunkler A, Cripe TP (2015) Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy. Pediatr Blood Cancer 62:5\u201311. https:\/\/doi.org\/10.1002\/pbc.25200. Epub 2014 Aug 30","journal-title":"Pediatr Blood Cancer"},{"key":"516_CR138","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1124\/mol.104.004713","volume":"67","author":"WM Suhre","year":"2005","unstructured":"Suhre WM, Ekins S, Chang C, Swaan PW, Wright SH (2005) Molecular determinants of substrate\/inhibitor binding to the human and rabbit renal organic cation transporters hOCT2 and rbOCT2. Mol Pharmacol 67:1067\u20131077","journal-title":"Mol Pharmacol"},{"key":"516_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2013.11.005","volume":"49","author":"S Sun","year":"2014","unstructured":"Sun S, Wang K, Lei H, Li L, Tu M, Zeng S, Zhou H, Jiang H (2014) Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine. Prog Neuropsychopharmacol Biol Psychiatry 49:1\u20136","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"516_CR140","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV (2019) Blood-brain barrier: from physiology to disease and back. Physiol Rev 99:21\u201378. https:\/\/doi.org\/10.1152\/physrev.00050.2017","journal-title":"Physiol Rev"},{"key":"516_CR141","doi-asserted-by":"publisher","unstructured":"Sweet DH (2021) Organic cation transporter expression and function in the CNS. Handb Exp Pharmacol. https:\/\/doi.org\/10.1007\/164_2021_463","DOI":"10.1007\/164_2021_463"},{"key":"516_CR142","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1124\/dmd.112.048181","volume":"41","author":"B Swift","year":"2013","unstructured":"Swift B, Nebot N, Lee JK, Han T, Proctor WR, Thakker DR, Lang D, Radtke M, Gnoth MJ, Brouwer KL (2013) Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites. Drug Metab Dispos 41:1179\u20131186","journal-title":"Drug Metab Dispos"},{"key":"516_CR143","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1124\/jpet.105.088104","volume":"315","author":"H Tahara","year":"2005","unstructured":"Tahara H, Kusuhara H, Endou H, Koepsell H, Imaoka T, Fuse E, Sugiyama Y (2005) A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters. J Pharmacol Exp Ther 315:337\u2013345","journal-title":"J Pharmacol Exp Ther"},{"key":"516_CR144","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1124\/jpet.300.3.918","volume":"300","author":"M Takeda","year":"2002","unstructured":"Takeda M, Khamdang S, Narikawa S, Kimura H, Kobayashi Y, Yamamoto T, Cha SH, Sekine T, Endou H (2002) Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther 300:918\u2013924","journal-title":"J Pharmacol Exp Ther"},{"key":"516_CR145","doi-asserted-by":"publisher","first-page":"7105","DOI":"10.1128\/AAC.01471-16","volume":"60","author":"LH Te Brake","year":"2016","unstructured":"Te Brake LH, van den Heuvel JJ, Buaben AO, van Crevel R, Bilos A, Russel FG, Aarnoutse RE, Koenderink JB (2016) Moxifloxacin is a potent in vitro inhibitor of OCT- and MATE-mediated transport of metformin and ethambutol. Antimicrob Agents Chemother 60:7105\u20137114","journal-title":"Antimicrob Agents Chemother"},{"key":"516_CR146","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1021\/mp400113d","volume":"10","author":"F Th\u00e9venod","year":"2013","unstructured":"Th\u00e9venod F, Ciarimboli G, Leistner M, Wolff NA, Lee WK, Schatz I, Keller T, Al-Monajjed R, Gorboulev V, Koepsell H (2013) Substrate- and cell contact-dependent inhibitor affinity of human organic cation transporter 2: studies with two classical organic cation substrates and the novel substrate cd21. Mol Pharm 10:3045\u20133056","journal-title":"Mol Pharm"},{"key":"516_CR147","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/0024-3205(78)90089-9","volume":"22","author":"U Trendelenburg","year":"1978","unstructured":"Trendelenburg U (1978) Extraneuronal uptake and metabolism of catecholamines as a site of loss. Life Sci 22:1217\u20131222. https:\/\/doi.org\/10.1016\/0024-3205(78)90089-9","journal-title":"Life Sci"},{"key":"516_CR148","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF00173580","volume":"339","author":"U Trendelenburg","year":"1989","unstructured":"Trendelenburg U (1989) The uptake and metabolism of 3H-catecholamines in rat cerebral cortex slices. Naunyn Schmiedebergs Arch Pharmacol 339:293\u2013297. https:\/\/doi.org\/10.1007\/BF00173580","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"516_CR508","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/clpt.2011.56","volume":"90","author":"MV Tzvetkov","year":"2011","unstructured":"Tzvetkov MV, Saadatmand AR, L\u00f6tsch J, Tegeder I, Stingl JC, Brockm\u00f6ller J (2011) Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol. Clin Pharmacol Ther 90(1):143\u2013150. https:\/\/doi.org\/10.1038\/clpt.2011.56. Epub 2011 May 11. PMID: 21562485","journal-title":"Clin Pharmacol Ther"},{"key":"516_CR149","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.bcp.2013.06.019","volume":"86","author":"MV Tzvetkov","year":"2013","unstructured":"Tzvetkov MV, dos Santos Pereira JN, Meineke I, Saadatmand AR, Stingl JC, Brockm\u00f6ller J (2013) Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration. Biochem Pharmacol 86:666\u2013678. https:\/\/doi.org\/10.1016\/j.bcp.2013.06.019. Epub 2013 Jul 5","journal-title":"Biochem Pharmacol"},{"key":"516_CR150","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/cpt.812","volume":"103","author":"MV Tzvetkov","year":"2018","unstructured":"Tzvetkov MV, Matthaei J, Pojar S, Faltraco F, Vogler S, Prukop T, Seitz T, Brockm\u00f6ller J (2018) Increased systemic exposure and stronger cardiovascular and metabolic adverse reactions to fenoterol in individuals with heritable OCT1 deficiency. Clin Pharmacol Ther 103:868\u2013878","journal-title":"Clin Pharmacol Ther"},{"key":"516_CR151","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1080\/00498250701397705","volume":"37","author":"K-I Umehara","year":"2007","unstructured":"Umehara K-I, Iwatsubo T, Noguchi K, Kamimura H (2007) Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H2-blockers on human and rat organic cation transporter-mediated transport: insight into the development of drug candidates. Xenobiotica 37:618\u2013634","journal-title":"Xenobiotica"},{"key":"516_CR152","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1080\/00498250802334409","volume":"38","author":"K-I Umehara","year":"2008","unstructured":"Umehara K-I, Iwatsubo T, Noguchi K, Usui T, Kamimura H (2008) Effect of cationic drugs on the transporting activity of human and rat OCT\/Oct 1-3 in vitro and implications for drug-drug interactions. Xenobiotica 38:1203\u20131218","journal-title":"Xenobiotica"},{"key":"516_CR153","first-page":"800","volume":"287","author":"Y Urakami","year":"1998","unstructured":"Urakami Y, Okuda M, Masuda S, Saito H, Inui KI (1998) Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. J Pharmacol Exp Ther 287:800\u20138005","journal-title":"J Pharmacol Exp Ther"},{"key":"516_CR154","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1023\/B:PHAM.0000029286.45788.ad","volume":"21","author":"Y Urakami","year":"2004","unstructured":"Urakami Y, Kimura N, Okuda M, Inui K (2004) Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney. Pharm Res 21:976\u2013981","journal-title":"Pharm Res"},{"key":"516_CR155","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1124\/dmd.118.081091","volume":"46","author":"M Visentin","year":"2018","unstructured":"Visentin M, Torozi A, Gai Z, H\u00e4usler S, Li C, Hiller C, Schraml PH, Moch H, Kullak-Ublick GA (2018) Fluorocholine transport mediated by the organic cation transporter 2 (OCT2, SLC22A2): implication for imaging of kidney tumors. Drug Metab Dispos 46:1129\u20131136","journal-title":"Drug Metab Dispos"},{"key":"516_CR156","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1124\/mol.109.054783","volume":"76","author":"C Volk","year":"2009","unstructured":"Volk C, Gorboulev V, Kotzsch A, M\u00fcller TD, Koepsell H (2009) Five amino acids in the innermost cavity of the substrate binding cleft of organic cation transporter 1 interact with extracellular and intracellular corticosterone. Mol Pharmacol 76:275\u2013289. https:\/\/doi.org\/10.1124\/mol.109.054783. Epub 2009 May 12","journal-title":"Mol Pharmacol"},{"key":"516_CR157","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1124\/dmd.116.074708","volume":"45","author":"DJ Wagner","year":"2017","unstructured":"Wagner DJ, Sager JE, Duan H, Isoherranen N, Wang J (2017) Interaction and transport of methamphetamine and its primary metabolites by organic cation and multidrug and toxin extrusion transporters. Drug Metab Dispos 45:770\u2013778","journal-title":"Drug Metab Dispos"},{"key":"516_CR158","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/cpt.442","volume":"100","author":"J Wang","year":"2016","unstructured":"Wang J (2016) The plasma membrane monoamine transporter (PMAT): structure, function, and role in organic cation disposition. Clin Pharmacol Ther 100:489\u2013499. https:\/\/doi.org\/10.1002\/cpt.442. Epub 2016 Sep 19","journal-title":"Clin Pharmacol Ther"},{"key":"516_CR159","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.pnpbp.2014.03.005","volume":"53","author":"K Wang","year":"2014","unstructured":"Wang K, Sun S, Li L, Tu M, Jiang H (2014) Involvement of organic cation transporter 2 inhibition in potential mechanisms of antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry 53:90\u201398","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"516_CR160","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00210-009-0459-z","volume":"380","author":"B Wenge","year":"2009","unstructured":"Wenge B, B\u00f6nisch H (2009) Interference of the noradrenergic neurotoxin DSP4 with neuronal and nonneuronal monoamine transporters. Naunyn Schmiedebergs Arch Pharmacol 380:523\u2013529","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"516_CR161","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00210-010-0590-x","volume":"383","author":"B Wenge","year":"2011","unstructured":"Wenge B, Geyer J, B\u00f6nisch H (2011) Oxybutynin and trospium are substrates of the human organic cation transporters. Naunyn Schmiedebergs Arch Pharmacol 383:203\u2013208","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"516_CR162","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/BF00169530","volume":"337","author":"VG Wilson","year":"1988","unstructured":"Wilson VG, Grohmann M, Trendelenburg U (1988) The uptake and O-methylation of 3H-(+\/\u2212)-isoprenaline in rat cerebral cortex slices. Naunyn Schmiedebergs Arch Pharmacol 337:397\u2013405. https:\/\/doi.org\/10.1007\/BF00169530","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"516_CR163","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1021\/mp100180a","volume":"8","author":"TN Winter","year":"2011","unstructured":"Winter TN, Elmquist WF, Fairbanks CA (2011) OCT2 and MATE1 provide bidirectional agmatine transport. Mol Pharm 8:133\u2013142","journal-title":"Mol Pharm"},{"key":"516_CR164","doi-asserted-by":"publisher","first-page":"32776","DOI":"10.1074\/jbc.273.49.32776","volume":"273","author":"X Wu","year":"1998","unstructured":"Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, Conway SJ, Ganapathy V (1998) Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 273:32776\u201332786","journal-title":"J Biol Chem"},{"key":"516_CR165","doi-asserted-by":"publisher","first-page":"F682","DOI":"10.1152\/ajprenal.00302.2006","volume":"292","author":"L Xia","year":"2007","unstructured":"Xia L, Engel K, Zhou M, Wang J (2007) Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells. Am J Physiol Renal Physiol 292:F682\u2013F690. https:\/\/doi.org\/10.1152\/ajprenal.00302.2006. Epub 2006 Oct 3","journal-title":"Am J Physiol Renal Physiol"},{"key":"516_CR166","doi-asserted-by":"publisher","first-page":"F1307","DOI":"10.1152\/ajprenal.00046.2009","volume":"296","author":"L Xia","year":"2009","unstructured":"Xia L, Zhou M, Kalhorn TF, Ho HT, Wang J (2009) Podocyte-specific expression of organic cation\u00a0transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity. Am J Physiol Renal Physiol 296:F1307\u2013F1313. https:\/\/doi.org\/10.1152\/ajprenal.00046.2009. Epub 2009 Apr 8","journal-title":"Am J Physiol Renal Physiol"},{"key":"516_CR167","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/978-981-13-7647-4_8","volume":"1141","author":"Y Xue","year":"2019","unstructured":"Xue Y, Ma C, Hanna I, Pan G (2019) Intestinal transporter-associated drug absorption and toxicity. Adv Exp Med Biol 1141:1361\u20131405. https:\/\/doi.org\/10.1007\/978-981-13-7647-4_8","journal-title":"Adv Exp Med Biol"},{"key":"516_CR168","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/978-981-13-7647-4_7","volume":"1141","author":"X Yang","year":"2019","unstructured":"Yang X, Han L (2019) Roles of renal drug transporter in drug disposition and renal toxicity. Adv Exp Med Biol 1141:341\u2013360. https:\/\/doi.org\/10.1007\/978-981-13-7647-4_7","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"516_CR509","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.apsb.2016.07.013","volume":"6","author":"J Yin","year":"2016","unstructured":"Yin J, Wang J (2016) Renal drug transporters and their significance in drug-drug interactions. Acta Pharm Sin B 6(5):363\u2013373. https:\/\/doi.org\/10.1016\/j.apsb.2016.07.013. Epub 2016 Aug 9. PMID: 27709005","journal-title":"Acta Pharm Sin B"},{"issue":"43","key":"516_CR169","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1124\/dmd.115.066175","volume":"2015","author":"J Yin","year":"2015","unstructured":"Yin J, Duan H, Shirasaka Y, Prasad B, Wang J (2015) Atenolol renal secretion is mediated by human organic cation transporter 2 and multidrug and toxin extrusion proteins. Drug Metab Dispos 2015(43):1872\u20131881","journal-title":"Drug Metab Dispos"},{"key":"516_CR170","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1124\/dmd.108.023168","volume":"36","author":"S Yokoo","year":"2008","unstructured":"Yokoo S, Masuda S, Yonezawa A, Terada T, Katsura T, Inui K-I (2008) Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer. Drug Metab Dispos 36:2299\u20132306. https:\/\/doi.org\/10.1124\/dmd.108.023168","journal-title":"Drug Metab Dispos"},{"key":"516_CR171","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1124\/jpet.106.110346","volume":"319","author":"A Yonezawa","year":"2006","unstructured":"Yonezawa A, Masuda S, Yokoo S, Katsura T, Inui K (2006) Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family). J Pharmacol Exp Ther 319:879\u2013886. https:\/\/doi.org\/10.1124\/jpet.106.110346. Epub 2006 Aug 16","journal-title":"J Pharmacol Exp Ther"},{"key":"516_CR172","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/164_2016_13","volume":"241","author":"T Yoshikawa","year":"2017","unstructured":"Yoshikawa T, Yanai K (2017) Histamine clearance through polyspecific transporters in the brain. Handb Exp Pharmacol 241:173\u2013187. https:\/\/doi.org\/10.1007\/164_2016_13","journal-title":"Handb Exp Pharmacol"},{"key":"516_CR173","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1124\/mol.51.6.913","volume":"51","author":"L Zhang","year":"1997","unstructured":"Zhang L, Dresser MJ, Gray AT, Yost SC, Terashita S, Giacomini KM (1997) Cloning and functional expression of a human liver organic cation transporter. Mol Pharmacol 51:913\u2013921","journal-title":"Mol Pharmacol"},{"key":"516_CR174","first-page":"354","volume":"286","author":"L Zhang","year":"1998","unstructured":"Zhang L, Schaner ME, Giacomini KM (1998) Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa). J Pharmacol Exp Ther 286:354\u2013361","journal-title":"J Pharmacol Exp Ther"},{"key":"516_CR175","first-page":"329","volume":"28","author":"L Zhang","year":"2000","unstructured":"Zhang L, Gorset W, Washington CB, Blaschke TF, Kroetz DL, Giacomini KM (2000) Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system. Drug Metab Dispos 28:329\u2013334","journal-title":"Drug Metab Dispos"},{"key":"516_CR176","doi-asserted-by":"publisher","first-page":"8847","DOI":"10.1158\/0008-5472.CAN-06-0769","volume":"66","author":"S Zhang","year":"2006","unstructured":"Zhang S, Lovejoy KS, Shima JE, Lagpacan LL, Shu Y, Lapuk A, Chen Y, Komori T, Gray JW, Chen X et al (2006) Organic cation transporters are determinants of oxaliplatin cytotoxicity. Cancer Res 66:8847\u20138857","journal-title":"Cancer Res"},{"key":"516_CR177","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1124\/dmd.107.015495","volume":"35","author":"M Zhou","year":"2007","unstructured":"Zhou M, Xia L, Wang J (2007) Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine. Drug Metab Dispos 35:1956\u20131962","journal-title":"Drug Metab Dispos"},{"key":"516_CR178","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1124\/dmd.110.032987","volume":"38","author":"M Zhou","year":"2010","unstructured":"Zhou M, Duan H, Engel K, Xia L, Wang J (2010) Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations. Drug Metab Dispos 38:1798\u20131805","journal-title":"Drug Metab Dispos"},{"key":"516_CR179","doi-asserted-by":"publisher","first-page":"628705","DOI":"10.3389\/fphar.2021.628705","volume":"12","author":"S Zhou","year":"2021","unstructured":"Zhou S, Zeng S, Shu Y (2021) Drug-drug interactions at organic cation transporter 1. Front Pharmacol 12:628705. https:\/\/doi.org\/10.3389\/fphar.2021.628705. eCollection 2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"516_CR180","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1471-4159.2010.06738.x","volume":"114","author":"H-J Zhu","year":"2010","unstructured":"Zhu H-J, Appel DI, Gr\u00fcndemann D, Markowitz JS (2010) Interaction of organic cation transporter 3 (SLC22A3) and amphetamine. J Neurochem 114(1):142\u2013149","journal-title":"J Neurochem"},{"key":"516_CR181","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00210-008-0369-5","volume":"379","author":"O Zolk","year":"2009","unstructured":"Zolk O, Solbach TF, Konig J, Fromm MF (2009) Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2). Naunyn Schmiedebergs Arch Pharmacol 379:337\u2013348","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"}],"container-title":["Handbook of Experimental Pharmacology","Organic Cation Transporters in the Central Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2021_516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T19:53:38Z","timestamp":1699732418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2021_516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030829834","9783030829841"],"references-count":191,"URL":"https:\/\/doi.org\/10.1007\/164_2021_516","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"9 September 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}